Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Zeng-Fei Xia"'
Autor:
Qiu-yun Luo, Tian Di, Miao-Zhen Qiu, Zeng-fei Xia, Yong Du, Run-duan Lin, Li-qiong Yang, Yu-ting Sun, Da-Jun Yang, Jian Sun, Lin Zhang
Publikováno v:
Cancer Cell International, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Esophageal squamous cell carcinoma (ESCC) is a severe disease with high mortality, and is associated with poor prognosis and frequent lymphatic metastasis. Therefore, prognostic indicators for ESCC are urgently needed. A-kinase an
Externí odkaz:
https://doaj.org/article/48c06573b6034c0998fcce7d460fbf17
Autor:
Fan Luo, Fei-Teng Lu, Miao-Zhen Qiu, Ting Zhou, Wen-Juan Ma, Min Luo, Kang-Mei Zeng, Qiu-Yun Luo, Wen-Tao Pan, Lin Zhang, Zeng-Fei Xia, Zhong-Han Zhang, Jia-Xin Cao, Hong-Yun Zhao, Li Zhang, Da-Jun Yang
Publikováno v:
Cell Death and Disease, Vol 12, Iss 8, Pp 1-14 (2021)
Abstract Advanced nasopharyngeal carcinoma (NPC) has a poor prognosis, with an unfavorable response to palliative chemotherapy. Unfortunately, there are few effective therapeutic regimens. Therefore, we require novel treatment strategies with enhance
Externí odkaz:
https://doaj.org/article/c8fd1d13c348483b94e5ed6a0209e578
Autor:
Qiu‐Yun Luo, Tian Di, Zhi‐Gang Chen, Jian‐Hong Peng, Jian Sun, Zeng‐Fei Xia, Wen‐Tao Pan, Fan Luo, Fei‐Teng Lu, Yu‐Ting Sun, Li‐Qiong Yang, Lin Zhang, Miao‐Zhen Qiu, Da‐Jun Yang
Publikováno v:
Cancer Science. 113:3330-3346
Colon cancer is the third most common cancer and the second leading cause of cancer-related death worldwide. Dysregulated RNA splicing factors have been reported to be associated with tumorigenesis and development in colon cancer. In this study, we i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aca96ec53dfadff35f9f4cc61bf83b40
https://doi.org/10.1111/cas.15480
https://doi.org/10.1111/cas.15480
Autor:
Fan Luo, Fei-Teng Lu, Jia-Xin Cao, Wen-Juan Ma, Zeng-Fei Xia, Jian-Hua Zhan, Kang-Mei Zeng, Yan Huang, Hong-Yun Zhao, Li Zhang
Publikováno v:
Cancer Letters. 531:39-56
The response to immune checkpoint inhibitors (ICIs) monotherapy remains unsatisfactory in patients with NSCLC. Thus, combining ICIs with other potential modalities is of great significance to enhance the response of single drug alone. Here, we identi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cc9f2ab341a50d2bde7e276bfe3fd62
https://doi.org/10.1016/j.canlet.2022.01.027
https://doi.org/10.1016/j.canlet.2022.01.027
Autor:
Qiu-yun Luo, Tian Di, Miao-Zhen Qiu, Zeng-fei Xia, Yong Du, Run-duan Lin, Li-qiong Yang, Yu-ting Sun, Da-Jun Yang, Jian Sun, Lin Zhang
Publikováno v:
Cancer cell international. 22(1)
Background Esophageal squamous cell carcinoma (ESCC) is a severe disease with high mortality, and is associated with poor prognosis and frequent lymphatic metastasis. Therefore, prognostic indicators for ESCC are urgently needed. A-kinase anchor-prot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a835e0dda9df6ba346669e0c32d8c26b
https://pubmed.ncbi.nlm.nih.gov/35189899
https://pubmed.ncbi.nlm.nih.gov/35189899
Autor:
Ting Zhou, Zeng-Fei Xia, Miao Zhen Qiu, Qiuyun Luo, Zhonghan Zhang, Wentao Pan, Fan Luo, Feiteng Lu, Min Luo, Hongyun Zhao, Li Zhang, Dajun Yang, Jia-Xin Cao, Wen-Juan Ma, Kangmei Zeng, Lin Zhang
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 12, Iss 8, Pp 1-14 (2021)
Cell Death and Disease, Vol 12, Iss 8, Pp 1-14 (2021)
Advanced nasopharyngeal carcinoma (NPC) has a poor prognosis, with an unfavorable response to palliative chemotherapy. Unfortunately, there are few effective therapeutic regimens. Therefore, we require novel treatment strategies with enhanced efficac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb46f46c7a7c2a0a55382f4b868e8ffb
https://doi.org/10.1038/s41419-021-04042-7
https://doi.org/10.1038/s41419-021-04042-7